Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityActive in the last 2 years

Nicole Groß

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8936-207X; OpenAlex author ID A5050486315. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
33
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: 3 papers · 2025: 1 paper · 2026: 2 papers

Papers 7

  1. Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-25-0331↗
  2. Cytometric Atlas of Combination Immunotherapy in Pancreatic Cancer: Blood-Based Signatures Reveal Vaccine and Checkpoint Inhibitor Responses. Co-author DOI 10.1158/2326-6066.cir-25-1126↗
  3. A phase 2 trial of CXCR4 antagonism and PD1 inhibition in metastatic pancreatic adenocarcinoma reveals recruitment of T cells but also immunosuppressive macrop… Co-author DOI 10.1080/2162402x.2025.2543614↗
  4. Multimodal immune phenotyping reveals microbial-T cell interactions that shape pancreatic cancer. Co-author DOI 10.1016/j.xcrm.2024.101397↗
  5. Entinostat in combination with nivolumab in metastatic pancreatic ductal adenocarcinoma: a phase 2 clinical trial. Co-author DOI 10.1038/s41467-024-52528-7↗
  6. Phosphodiesterase-5 inhibition collaborates with vaccine-based immunotherapy to reprogram myeloid cells in pancreatic ductal adenocarcinoma. Co-author DOI 10.1172/jci.insight.179292↗
  7. Multi-omic profiling of lung and liver tumor microenvironments of metastatic pancreatic cancer reveals site-specific immune regulatory pathways. Co-author DOI 10.1186/s13059-021-02363-6↗

Closest collaborators

The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Won Jin Ho · 7 shared papers, 2021–2026 · strength 1.17
  2. Elizabeth M. Jaffee · 6 shared papers, 2021–2026 · strength 1.01
  3. Elana Judith Fertig · 5 shared papers, 2021–2026 · strength 0.82
  4. Jae Woo Lee · 3 shared papers, 2024–2026 · strength 0.57
  5. Dung Thi Le · 3 shared papers, 2024–2026 · strength 0.56
  6. Katherine M. Bever · 3 shared papers, 2024–2026 · strength 0.56
  7. Dimitrios N. Sidiropoulos · 3 shared papers, 2024–2026 · strength 0.53
  8. Jacob T. Mitchell · 2 shared papers, 2024–2026 · strength 0.35
  9. Luciane Tsukamoto Kagohara · 2 shared papers, 2024–2026 · strength 0.35
  10. Yeonju Cho · 2 shared papers, 2024–2026 · strength 0.35
  11. Mark M. Yarchoan · 2 shared papers, 2021–2024 · strength 0.26
  12. Hao Wang · 1 shared paper, 2026 · strength 0.22
  13. William Reece Burns · 1 shared paper, 2026 · strength 0.19
  14. Christopher R. Shubert · 1 shared paper, 2026 · strength 0.19
  15. Jin Peng He · 1 shared paper, 2026 · strength 0.19
  16. Samantha R. Guinn · 1 shared paper, 2026 · strength 0.19
  17. Kelly J. Lafaro · 1 shared paper, 2026 · strength 0.19
  18. Daniel J. Zabransky · 1 shared paper, 2026 · strength 0.19
  19. Norman G. Nicolson · 1 shared paper, 2026 · strength 0.19
  20. Richard Andrew Burkhart · 1 shared paper, 2026 · strength 0.19
  21. Kylie Belanger · 1 shared paper, 2026 · strength 0.19
  22. Michael Goggins · 1 shared paper, 2026 · strength 0.19
  23. Lei Zheng · 1 shared paper, 2026 · strength 0.19
  24. Jacquelyn W. Zimmerman · 1 shared paper, 2026 · strength 0.19
  25. Robert A. Anders · 1 shared paper, 2025 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.